查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1861524

医疗资产管理市场：2025-2032年全球预测（医疗设备、资讯科技基础设施、设施管理、製药和实验室设备划分）

Healthcare Asset Management Market by Medical Equipment, Information Technology Infrastructure, Facilities Management, Pharmaceuticals, Laboratory Instruments - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，医疗保健资产管理市场将成长至 276.1 亿美元，复合年增长率为 6.84%。

关键市场统计数据
基准年 2024 162.5亿美元
预计年份：2025年 173.8亿美元
预测年份 2032 276.1亿美元
复合年增长率 (%) 6.84%

医疗资产管理正经历一场策略转型，其驱动力来自多重压力：科技加速普及、监管审查日益严格，以及如何最大化现有资本投资的价值。管理影像和实验室设备、药品、 IT基础设施以及设施系统的大型机构面临着双重挑战：既要维持临床营运的连续性，又要整合新的数位化功能，以实现预测性维护、远端监控和更有效率的利用率追踪。

随着医院和综合医疗网络将韧性置于优先地位，它们正将工作重点从被动维护转向基于生命週期的资产管治。这种转变体现在对资产标籤、集中式资料平台以及连接采购、临床工程和财务团队的成熟管治流程的投资。这些变革并非可有可无，而是管理风险、实现临床品质指标、控制营运成本的必要条件。此外，战略观点已超越单一资产，涵盖设备群、软体生态系统和设施网路。这种整体观点需要跨学科协作以及清晰的技术应用和人才培养蓝图。

数位化、不断变化的法规、网路安全和劳动力动态正在汇聚，重新定义医疗保健资产管理的优先事项和营运模式。

医疗资产管理格局正在发生变革，这既带来了机会，也带来了风险。数位化转型是其中最显着的因素。连网影像设备、具备分析功能的资产管理软体以及云端託管的IT基础设施正在改变医疗机构监控资产健康状况和分配资源的方式。这个数位化层面实现了远距离诊断和预测性维护，但也扩大了网路安全威胁的攻击面，因此临床工程部门和IT安全部门之间加强风险管理协作的需求日益增长。

同时，监管和合规框架也在不断发展，以反映对病人安全和资料隐私的关注。医疗设备互通性、软体检验和供应链透明度的更严格标准要求医疗机构记录关键资产的来源和生命週期事件。此外，劳动力结构的变化，例如熟练生物医学工程师的短缺以及对第一线员工资料素养的新要求，也在重塑营运模式。为了因应这些变革，领导者必须优先考虑跨职能培训，投资于可互操作系统，并实施严格的供应商管治措施，以确保技术进步能够转化为在运转率、病患安全和财务管理方面可衡量的改进。

对2025年关税如何重塑医疗资产类别的采购经济、备品策略和供应商在地化决策全面评估

2025年即将实施的新关税为医疗资产管理者带来了更复杂的成本、供应链和策略采购挑战。这些关税影响成品医疗设备和中间组件，改变了诊断影像设备、伺服器、网路设备、实验室设备和某些药品原料的采购经济效益。采购团队现在必须权衡短期成本影响与供应商多元化、近岸外包和长期服务协议等策略优势，这些措施可以保护企业免受关税短期波动的影响。

除了采购之外，关税还会对维护策略和备件库存产生间接影响。设施管理和临床工程部门正在调整库存策略，以确保临床设备的可用性，同时避免将过多资金投入可能过时的零件。同时，供应商也重新评估其分销网络，重新谈判服务水准协议，并实现部分生产流程的本地化。这些发展为医疗机构提供了重新谈判总体拥有成本条款并寻求提高生命週期支持透明度的机会。最终，资产负责人必须将关税情境纳入其资本规划和供应商选择流程，以确保医疗服务的连续性，同时保持财务纪律和供应商课责。

医疗资产管理细分领域的清晰化：将设备类型、 IT基础设施、设施系统、药品和实验室设备与业务优先顺序保持一致。

了解细分市场对于制定有针对性的资产管理策略至关重要，因为每项资产都有不同的营运、维护和监管要求。以医疗设备为例，市场可分为诊断影像设备、病患监测系统及手术器材。诊断影像设备可细分为CT扫描仪和核磁共振造影系统，手术器械则分为一般手术器械和微创手术器械。每个子集都需要各自的维护通讯协定、校准週期和临床使用规则。以资讯科技基础设施为例，市场可分为硬体、服务和软体。硬体可细分为网路设备和伺服器，软体则分为分析软体和资产管理软体。这些区分为本地部署与云端部署、修补程式更新频率和整合优先顺序等决策提供了重要资讯。

在设施管理领域，市场分析涵盖建筑自动化、清洁和安防系统。建筑自动化进一步细分为暖通空调系统和照明控制系统，安防系统则细分为门禁系统和监控系统。这些类别驱动着能源管理措施，并影响病患流动和安全通讯协定。在製药领域，市场分析涵盖生物製药、品牌药和学名药。生物製药细分为单株抗体和重组蛋白，品牌药细分为循环系统和肿瘤药物。这种分类影响低温运输物流、存货周转政策和监管文件。基于实验室设备的市场分析分为分析设备和生命科学设备。分析设备细分为层析法和光谱系统，而生命科学设备包括细胞分析系统和PCR系统。实验室设备的细分决定了校准要求、耗材规划和生物安全考虑。

认识到这些不同的细分市场，资产管理者可以优先考虑平衡临床影响、生命週期成本和监管合规性的干预措施，并促进筹资策略，使供应商的能力与特定资产类别的要求保持一致，从而提高服务可靠性并减少下游营运摩擦。

区域策略考量在资产管理中体现了全球市场供应链、管理体制和技术采用模式的多样性。

区域环境影响资产策略，因为供应链、管理体制和临床工作流程在不同地区差异显着。在美洲，采购週期和报销机制往往优先考虑快速采用先进的影像和监控技术，因此重点在于整合、正常运作和灵活的资金筹措。在欧洲、中东和非洲，监管协调、市场成熟度差异以及基础设施差异正在推动对模组化解决方案和多层级服务模式的需求，这些方案和模式能够适应从都市区三级医疗中心到农村医疗机构的各种需求。在亚太地区，数位化平台的快速普及、医院容量的扩张以及本地製造能力的增强正在加速对互联IT基础设施和设施自动化的投资。

这些区域差异意味着一刀切的资产管理方法行不通。相反，各机构应采取区域差异化的筹资策略，充分考虑供应商的企业发展、监管时间表和技术人才的可用性。此外，资本负责人应纳入区域风险评估，包括政治、贸易和物流因素，以确保应对挑战的能力。最终，区域洞察应指导供应商选择、备件策略和培训计划，确保本地支援与集中管理相结合，从而在各种不同的环境中提供一致的患者照护服务。

供应商的产品蓝图、服务模式和管治实务如何决定医疗保健资产组合的长期价值和可靠性

主要企业透过其产品蓝图、服务模式和伙伴关係方式塑造资产管理生态系统，进而影响医疗服务提供者的选择。那些整合强大的远距离诊断功能、提供标准化互通性框架并承诺透明的生命週期支援协议的供应商，对于那些寻求最大限度减少停机时间并获取营运情报的医疗系统而言，是理想的策略合作伙伴。同样重要的是，能够将技术维护与分析能力相结合，从而实现预测性维护计划的服务供应商，这有助于提高设备可用性并有效利用临床资源。

除了产品和服务能力之外，供应商管治也至关重要。企业应根据备件物流、韧体和软体更新频率、网路安全措施以及认证现场服务工程师的可用性等标准来评估供应商。与供应商就数据共用协议和按绩效付费合约开展合作，有助于奖励双方提高运转率并降低整体维护成本。最后，那些致力于透过培训、认证和远端支援来赋能员工和进行知识转移的公司，将更有能力支援复杂资产组合的长期营运韧性和技术应用。

整合管治、采购、技术和人才策略，以增强医疗保健资产的韧性和价值的实用有效的领导策略

行业领导者必须将洞察转化为可执行的行动，以提升韧性并优化资产绩效。首先，企业应采用生命週期管治模型，并利用统一的指标管理运转率、使用率和合规性。此模型规范了资产标籤、文件和交接流程，即使在所有权变更和服务合约转换的情况下，也能确保问责制和资料完整性。

第二，领导者应优先投资于可互通的资产管理软体和分析平台，这些平台能够提供统一的介面，方便查看设备运作状况、维护计画和备件预测。此类平台支援预测性维护计划，并能减少被动维护的工作量。第三，筹资策略应转向总拥有成本合同，此类合约应包含明确的性能保证、明确的备件供应以及与服务绩效挂钩的处罚或补偿。第四，为解决技术人员短缺问题，各组织应投资加强远端支援能力、实施交叉培训，并与供应商建立策略伙伴关係，以提升现场服务水准。最后，资本规划应纳入地缘政治和关税风险评估，并考虑供应商多元化和近岸外包方案，以确保服务连续性，同时维持财务纪律。

调查方法结合了现场访谈、技术文件和基于情境的供应链分析，旨在得出切实可行且检验的资产管理见解。

本研究整合了定性和定量信息，以确保提供平衡且实用的见解。主要资讯来源包括对临床工程师、采购人员、医院营运主管和供应商服务经理的访谈，以收集有关维护实务、备件物流和供应商绩效的实地观点。二级资讯来源包括官方监管文件、医疗设备和IT系统技术标准、产业白皮书以及展示成功实施案例的研究。对主要和二级资讯来源进行交叉检验，确保结论既反映实际情况，又符合既定标准。

我们的分析方法着重于三角测量和情境分析，而非预测建模。我们的资产类别分析利用设备技术手册、服务等级协定和实际服务日誌，识别常见故障模式、维护频率以及软体更新与设备运转率之间的相关性。我们的区域和关税影响评估依赖供应链映射和供应商布局分析，以可视化潜在的营运应对措施，而无需依赖市场规模估算。我们的调查方法强调假设的透明度、数据来源的清晰记录以及敏感性检验，以确保我们的建议在各种运营条件下都具有稳健性。

概述重点在于生命週期管治、互操作系统和供应链弹性，以确保医疗服务的连续性和营运绩效。

总之，医疗资产管理正处于一个策略转折点，技术创新、监管变革和供应链动态交织在一起，重新定义了营运重点。未来发展需要各机构从各自独立的维护实践转向以生命週期为中心的管治，采用能够实现预测性维护的互通性技术，并实施使供应商激励机制与临床可用性相一致的筹资策略。关税相关的波动凸显了奖励供应策略和透明的供应商合约对于保障医疗服务连续性的重要性。

透过结合强有力的管治、有针对性的技术投资和灵活的采购惯例，果断的领导者可以确保可靠的临床运营，并从现有资产中挖掘更大价值。持续改进依赖临床工程、IT、采购和供应商合作伙伴之间的协作关係，并以一致的数据管理和人才培养为支撑。遵循本报告中提出的建议和框架，各机构可以更好地应对新兴风险，并抓住机会，从而改善患者预后并提高营运效率。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 引入人工智慧驱动的预测性维护，以减少关键医疗设备的停机时间
  • 实施基于区块链的供应链追踪系统，以验证医疗设备的真实性并确保合规性
  • 将医院工作流程管理平台与基于物联网的即时位置资讯系统整合以提高效率
  • 实施集中式多站点资产管理系统，实现联合资料存取与分析
  • 采用内建网路安全和资料隐私控制功能的云端原生解决方案
  • 实施医疗设备的永续性生命週期管理策略，包括对环境负责的处置方法
  • 利用数位双胞胎技术对医疗设备性能和维护进行虚拟模拟和最佳化

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 医疗医疗设备资产管理市场

  • 诊断影像设备
    • 电脑断层扫描器
    • 磁振造影
  • 病患监测系统
  • 手术器械
    • 一般外科器械
    • 微创手术器械

9. 资讯科技基础设施驱动的医疗保健资产管理市场

  • 硬体
    • 网路装置
    • 伺服器
  • 服务
  • 软体
    • 分析软体
    • 资产管理软体

第十章：按设施管理分類的医疗保健资产管理市场

  • 建筑自动化
    • 暖通空调系统
    • 照明控制系统
  • 清洁工作
  • 安全系统
    • 门禁系统
    • 监控系统

第十一章：按药物分類的医疗资产管理市场

  • 生物製药
    • 单株抗体
    • 重组蛋白
  • 品牌药
    • 循环系统药物
    • 抗癌药物
  • 学名药

第十二章 医疗资产管理市场（依检测设备划分）

  • 分析设备
    • 层析法系统
    • 光谱分析仪
  • 生命科学设备
    • 细胞分析仪
    • PCR系统

第十三章：按地区分類的医疗保健资产管理市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：依集团分類的医疗保健资产管理市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国医疗保健资产管理市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • GE HealthCare Technologies Inc.
    • Koninklijke Philips NV
    • Siemens Healthineers AG
    • McKesson Corporation
    • Cardinal Health, Inc.
    • Baxter International Inc.
    • Abbott Laboratories
    • Oracle Corporation
    • Accruent, LLC
    • International Business Machines Corporation
Product Code: MRR-69324464D212

The Healthcare Asset Management Market is projected to grow by USD 27.61 billion at a CAGR of 6.84% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 16.25 billion
Estimated Year [2025] USD 17.38 billion
Forecast Year [2032] USD 27.61 billion
CAGR (%) 6.84%

Healthcare asset management is undergoing a strategic reorientation driven by simultaneous pressures: accelerating technology adoption, heightened regulatory scrutiny, and the imperative to extract greater value from existing capital investments. Organizations that manage portfolios spanning imaging devices, laboratory instruments, pharmaceuticals, IT infrastructure, and facility systems are confronted with the dual challenge of sustaining uninterrupted clinical operations while integrating new digital capabilities that promise predictive maintenance, remote monitoring, and improved utilization tracking.

As hospitals and integrated delivery networks prioritize resilience, they are reallocating attention from reactive maintenance to lifecycle-based asset governance. This shift manifests through investments in asset tagging, centralized data platforms, and mature governance processes that align procurement, clinical engineering, and finance teams. These changes are not optional; rather, they are essential to manage risk, meet clinical quality metrics, and control operational costs. Moreover, the strategic lens now extends beyond individual assets to encompass networks of devices, software ecosystems, and facilities - a holistic view that requires cross-disciplinary collaboration and a clear roadmap for technology adoption and workforce development.

How digitalization, regulatory evolution, cybersecurity and workforce dynamics are jointly redefining priorities and operating models in healthcare asset management

The landscape of healthcare asset management is shifting in ways that reconfigure both opportunity and risk. Digital transformation is the most visible force: internet-connected imaging equipment, analytics-enabled asset management software, and cloud-hosted IT infrastructure are changing how organizations monitor asset health and allocate resources. This digital layer enables remote diagnostics and predictive maintenance, yet it also increases the attack surface for cybersecurity threats, intensifying the need for coordinated risk management across clinical engineering and IT security functions.

Concurrently, regulatory and compliance frameworks are evolving to reflect patient safety concerns and data privacy imperatives. Stricter standards for device interoperability, software validation, and supply chain transparency compel providers to document provenance and lifecycle events for critical assets. At the same time, workforce dynamics - including shortages in skilled biomedical technicians and new expectations for data literacy among frontline staff - are reshaping operational models. These transformative shifts require leaders to prioritize cross-functional training, invest in interoperable systems, and adopt rigorous vendor governance practices to ensure that technological gains translate into measurable improvements in uptime, patient safety, and fiscal stewardship.

Comprehensive assessment of how 2025 tariff actions are reshaping procurement economics, spare parts strategies and supplier localization decisions across healthcare assets

The introduction of new tariff measures in 2025 has created a complex overlay of cost, supply chain, and strategic sourcing considerations for healthcare asset managers. Tariffs affect both finished medical goods and intermediate components, altering procurement economics for imaging equipment, servers, networking hardware, laboratory instruments, and certain pharmaceutical inputs. Procurement teams must now weigh the immediate cost implications against the strategic benefits of supplier diversification, nearshoring, and long-term service agreements that insulate organizations from episodic tariff volatility.

Beyond procurement, tariffs have second-order effects on maintenance strategies and spare parts inventories. Facilities and clinical engineering departments are adjusting stocking policies to maintain clinical availability while avoiding excessive capital tied up in parts that risk obsolescence. In parallel, vendors are responding by revising distribution footprints, renegotiating service-level commitments, and localizing certain manufacturing processes. These responses create opportunities for healthcare organizations to renegotiate total-cost-of-ownership terms and to demand greater transparency in lifecycle support. Ultimately, asset managers must incorporate tariff scenarios into capital planning and vendor selection processes, ensuring continuity of care while preserving fiscal discipline and supplier accountability.

Segment-level clarity for healthcare asset management that aligns device types, IT infrastructure, facility systems, pharmaceuticals and laboratory equipment with operational priorities

Understanding segmentation is essential for targeted asset management strategies because assets exhibit distinct operational, maintenance, and regulatory profiles. Based on Medical Equipment, the market is studied across Imaging Equipment, Patient Monitoring Systems, and Surgical Instruments, with Imaging Equipment further examined through Computed Tomography Scanners and Magnetic Resonance Imaging Machines, and Surgical Instruments differentiated into General Surgical Instruments and Minimally Invasive Instruments; each subset requires tailored maintenance protocols, calibration cycles, and clinical utilization rules. Based on Information Technology Infrastructure, the market is studied across Hardware, Services, and Software, with Hardware further divided into Networking Equipment and Servers, and Software segmented into Analytics Software and Asset Management Software; these distinctions inform decisions about on-premises versus cloud deployments, patching cadences, and integration priorities.

In Facilities Management, the market is studied across Building Automation, Housekeeping, and Security Systems, with Building Automation further studied across HVAC Systems and Lighting Control Systems, and Security Systems distinguished into Access Control Systems and Surveillance Systems; these categories drive energy management initiatives and influence patient flow and safety protocols. Based on Pharmaceuticals, the market is studied across Biopharmaceuticals, Branded Drugs, and Generic Drugs, with Biopharmaceuticals further analyzed as Monoclonal Antibodies and Recombinant Proteins, and Branded Drugs examined through Cardiovascular Drugs and Oncology Drugs; pharmaceutical segmentation affects cold chain logistics, inventory turnover policies, and regulatory documentation. Based on Laboratory Instruments, the market is studied across Analytical Instruments and Life Science Instruments, with Analytical Instruments subdivided into Chromatography Systems and Spectroscopy Instruments, and Life Science Instruments including Cell Analysis Instruments and PCR Systems; laboratory segmentation determines calibration requirements, consumables planning, and biosafety considerations.

Recognizing these discrete segments enables asset managers to prioritize interventions that balance clinical impact, lifecycle costs, and regulatory compliance. It also facilitates procurement strategies that align vendor capabilities with specific asset-class requirements, thereby improving service reliability and reducing downstream operational friction.

Regional strategic considerations for asset management that reflect supply chain diversity, regulatory regimes and technology adoption patterns across global markets

Regional context shapes asset strategies because supply chains, regulatory regimes, and clinician workflows vary significantly across geographies. In the Americas, procurement cycles and reimbursement structures often prioritize rapid deployment of advanced imaging and monitoring technologies, which drives a focus on integration, uptime guarantees, and flexible financing. In Europe, Middle East & Africa, regulatory harmonization, diverse market maturities, and infrastructure variability create demand for modular solutions and multi-tiered service models that can be adapted to both urban tertiary centers and rural facilities. In Asia-Pacific, rapid adoption of digital platforms, expanding hospital capacity, and localized manufacturing capacities are accelerating investments in interconnected IT infrastructure and facility automation.

These regional distinctions mean that a one-size-fits-all approach to asset management is ineffective. Instead, organizations should adopt regionally differentiated procurement playbooks that account for vendor footprints, regulatory timelines, and the availability of technical talent. Moreover, capital planners should incorporate regional risk assessments - including political, trade, and logistical considerations - to ensure resilience. Ultimately, regional insights should inform vendor selection, spare parts strategies, and training programs so that the right mix of local support and centralized governance delivers consistent patient outcomes across diverse settings.

How vendor product roadmaps, service models and governance practices determine long-term value and reliability in healthcare asset portfolios

Key companies shape the asset management ecosystem through product roadmaps, service models, and partnership approaches that influence provider choices. Vendors that integrate robust remote diagnostics, offer standardized interoperability frameworks, and commit to transparent lifecycle support agreements stand out as strategic partners for healthcare systems aiming to minimize downtime while capturing operational intelligence. Equally important are service providers that can couple technical maintenance with analytics capabilities, enabling predictive maintenance programs that translate into higher equipment availability and more efficient utilization of clinical capacity.

In addition to product and service capabilities, vendor governance matters. Organizations should evaluate suppliers on criteria such as spare parts logistics, firmware and software update cadences, cybersecurity practices, and the availability of accredited field service engineers. Collaboration with vendors on data-sharing agreements and performance-based contracts can align incentives toward improved uptime and reduced total cost of care. Finally, companies that demonstrate commitment to workforce enablement and knowledge transfer - through training, certification, and remote support - will be better positioned to support long-term operational resilience and technology adoption across complex asset portfolios.

Practical, high-impact actions for leaders to align governance, procurement, technology and workforce strategies to strengthen healthcare asset resilience and value

Industry leaders must translate insights into executable actions that strengthen resilience and optimize asset performance. First, organizations should adopt a lifecycle governance model that integrates procurement, clinical engineering, finance, and IT under unified metrics for uptime, utilization, and compliance. This governance model should standardize asset tagging, documentation, and handoff processes so that accountability and data integrity persist across ownership changes and service contracts.

Second, leaders should prioritize investments in interoperable asset management software and analytics platforms that provide a single pane of glass for device health, maintenance scheduling, and spare parts forecasting. Such platforms enable predictive programs and reduce reactive maintenance workloads. Third, procurement strategies should shift toward total-cost-of-ownership contracts that include clear performance guarantees, defined spare parts availability, and penalties or credits tied to service outcomes. Fourth, workforce strategies must address technician shortages by investing in remote support capabilities, cross-training, and strategic partnerships with vendors for field service augmentation. Finally, leaders should incorporate geopolitical and tariff risk assessments into capital planning, diversifying suppliers and evaluating nearshoring options to preserve continuity of care while maintaining fiscal discipline.

Methodological approach that integrates frontline interviews, technical documentation and scenario-based supply chain analysis to produce practical and verifiable asset management insights

This research synthesizes qualitative and quantitative inputs to ensure balanced, actionable findings. Primary inputs include interviews with clinical engineers, procurement leaders, hospital operations executives, and vendor service managers to capture frontline perspectives on maintenance practices, spare parts logistics, and vendor performance. Secondary inputs comprise public regulatory documents, technical standards for medical devices and IT systems, industry white papers, and case studies demonstrating deployment outcomes. Cross-validation between primary and secondary sources ensures that conclusions reflect both lived operational realities and established standards.

Analytical methods emphasize triangulation and scenario analysis rather than predictive modeling. Asset-class analyses draw on device technical manuals, service-level agreements, and real-world service logs to identify common failure modes, maintenance cadences, and the interplay between software updates and device availability. For regional and tariff impact assessments, supply chain mapping and supplier footprint analysis were conducted to illustrate likely operational responses without relying on market sizing estimates. The methodology favors transparent assumptions, clearly documented data sources, and sensitivity checks to ensure that recommendations remain robust under varying operational conditions.

Concluding synthesis emphasizing lifecycle governance, interoperable systems and supply chain resilience to secure continuity of care and operational performance

In conclusion, healthcare asset management is at a strategic inflection point where technology, regulatory change, and supply chain dynamics converge to redefine operational priorities. The path forward requires organizations to move from siloed maintenance practices to lifecycle-centered governance, to adopt interoperable technologies that enable predictive maintenance, and to implement procurement strategies that align vendor incentives with clinical availability. Tariff-related disruptions underscore the importance of diversified supply strategies and transparent vendor agreements that protect continuity of care.

Leaders who act decisively will secure reliable clinical operations and extract greater value from existing assets by combining robust governance, targeted technology investments, and adaptive procurement practices. Sustained improvements will depend on collaborative relationships across clinical engineering, IT, procurement, and supplier partners, supported by consistent data practices and workforce development. By following the recommendations and frameworks presented in this report, organizations can strengthen readiness for emerging risks and capitalize on opportunities to enhance patient outcomes and operational efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Implementation of AI-driven predictive maintenance for critical medical equipment to reduce downtime
  • 5.2. Adoption of blockchain-enabled supply chain tracking for enhanced medical device authentication and compliance
  • 5.3. Integration of IoT-based real-time location systems with hospital workflow management platforms for efficiency gains
  • 5.4. Deployment of centralized multi-site asset management systems with federated data access and analytics capabilities
  • 5.5. Adoption of cloud-native healthcare asset management solutions with embedded cybersecurity and data privacy controls
  • 5.6. Implementation of sustainability-driven lifecycle management strategies for medical equipment including green disposal methods
  • 5.7. Utilization of digital twin technology for virtual simulation and optimization of medical device performance and maintenance

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Healthcare Asset Management Market, by Medical Equipment

  • 8.1. Imaging Equipment
    • 8.1.1. Computed Tomography Scanners
    • 8.1.2. Magnetic Resonance Imaging Machines
  • 8.2. Patient Monitoring Systems
  • 8.3. Surgical Instruments
    • 8.3.1. General Surgical Instruments
    • 8.3.2. Minimally Invasive Instruments

9. Healthcare Asset Management Market, by Information Technology Infrastructure

  • 9.1. Hardware
    • 9.1.1. Networking Equipment
    • 9.1.2. Servers
  • 9.2. Services
  • 9.3. Software
    • 9.3.1. Analytics Software
    • 9.3.2. Asset Management Software

10. Healthcare Asset Management Market, by Facilities Management

  • 10.1. Building Automation
    • 10.1.1. HVAC Systems
    • 10.1.2. Lighting Control Systems
  • 10.2. Housekeeping
  • 10.3. Security Systems
    • 10.3.1. Access Control Systems
    • 10.3.2. Surveillance Systems

11. Healthcare Asset Management Market, by Pharmaceuticals

  • 11.1. Biopharmaceuticals
    • 11.1.1. Monoclonal Antibodies
    • 11.1.2. Recombinant Proteins
  • 11.2. Branded Drugs
    • 11.2.1. Cardiovascular Drugs
    • 11.2.2. Oncology Drugs
  • 11.3. Generic Drugs

12. Healthcare Asset Management Market, by Laboratory Instruments

  • 12.1. Analytical Instruments
    • 12.1.1. Chromatography Systems
    • 12.1.2. Spectroscopy Instruments
  • 12.2. Life Science Instruments
    • 12.2.1. Cell Analysis Instruments
    • 12.2.2. PCR Systems

13. Healthcare Asset Management Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Healthcare Asset Management Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Healthcare Asset Management Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. GE HealthCare Technologies Inc.
    • 16.3.2. Koninklijke Philips N.V.
    • 16.3.3. Siemens Healthineers AG
    • 16.3.4. McKesson Corporation
    • 16.3.5. Cardinal Health, Inc.
    • 16.3.6. Baxter International Inc.
    • 16.3.7. Abbott Laboratories
    • 16.3.8. Oracle Corporation
    • 16.3.9. Accruent, LLC
    • 16.3.10. International Business Machines Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. HEALTHCARE ASSET MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. HEALTHCARE ASSET MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HEALTHCARE ASSET MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT,